Betamipron (CS-443) is a nephroprotective agent co-administered with the carbapenem antibiotic panipenem. It functions by competitively inhibiting the renal tubular uptake of panipenem, thereby reducing its nephrotoxic potential. This combination is utilized in research models to study antibiotic-induced kidney injury and protective pharmacological strategies.